Identification of the Major Oxidative 3α-Hydroxysteroid Dehydrogenase in Human Prostate That Converts 5α-Androstane-3α,17β-diol to 5α-Dihydrotestosterone: A Potential Therapeutic Target for Androgen-De…

Overview of attention for article published in Molecular Endocrinology, September 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

patent: 3 patents

Readers on

mendeley: 42 Mendeley

Summary Patents

So far, Altmetric has seen 3 patents that reference this research output.

Treatment of metastatic prostate cancer

Grant US-11215617-B2

United States of America

INHIBITION OF CATALYTIC SITE COMMON TO MULTIPLE 3 ALPHA-OXIDOREDUCTASES FOR TREATMENT OF…

Application WO-2017165886-A1

World Intellectual Property Organisation (WIPO)

TREATMENT OF METASTATIC PROSTATE CANCER

Application WO-2015065919-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.